Back

Neutrophil–lymphocyte ratio in the immune checkpoint inhibitors-related atherosclerosis

European Heart Journal

22 March 2021
Organised by: Logo
Read full article
ESC Journals CARDIOVASCULAR DISEASE IN SPECIFIC POPULATIONS BASIC SCIENCE

Contributors

Nan Zhang
Nan Zhang

Author

Gary Tse
Gary Tse

Author

Hong Kong Metropolitan University Hong Kong , China

Tong Liu
Tong Liu

Author

2nd Hospital of Tianjin Medical University Tianjin , China

You may be interested in
thumbnail
Webinar
Recent advances in immune pathways in atherosclerosis
21 April 2021
thumbnail
Congress Presentation
Neutrophil-to-lymphocyte ratio as a prognostic factor in patients with acute pulmonary embolism on the background of oncological disease
21 June 2025
thumbnail
Congress Presentation
Cardiotoxicity and immune checkpoint inhibitors: a heartfelt myth or the real deal?
20 May 2025
thumbnail
Congress Presentation
Immune checkpoint inhibition increases aortic inflammation on 18F-FDG PET/CT: a retrospective cohort study in patients with Merkel cell carcinoma receiving avelumab
21 June 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources